CV Sciences Capital Expenditures (CapEx) Growth & History (CVSI)
CV Sciences's capital expenditures (capex) was $109,000 for fiscal 2025.
View full CV Sciences company overviewCV Sciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $109,000 | $91,000 | +505.56% |
| 2024 | 2024-12-31 | $18,000 | $18,000 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$35,000 | — |
| 2021 | 2021-12-31 | $35,000 | −$1.0M | −96.69% |
| 2020 | 2020-12-31 | $1.1M | −$90,000 | −7.85% |
| 2019 | 2019-12-31 | $1.1M | $254,000 | +28.44% |
| 2018 | 2018-12-31 | $893,000 | $439,000 | +96.70% |
| 2017 | 2017-12-31 | $454,000 | $436,793 | +2538.46% |
| 2016 | 2016-12-31 | $17,207 | −$96,320 | −84.84% |
| 2015 | 2015-12-31 | $113,527 | −$335,684 | −74.73% |
| 2014 | 2014-12-31 | $449,211 | $222,617 | +98.24% |
| 2013 | 2013-12-31 | $226,594 | $226,594 | — |
| 2012 | 2012-12-31 | $0 | — | — |
CV Sciences quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7,000 | −$42,000 | −85.71% |
| Q1 2026 | 2026-03-31 | $3,000 | −$37,000 | −92.50% |
| Q4 2025 | 2025-12-31 | $9,000 | −$9,000 | −50.00% |
| Q3 2025 | 2025-09-30 | $11,000 | $11,000 | — |
| Q2 2025 | 2025-06-30 | $49,000 | $49,000 | — |
| Q1 2025 | 2025-03-31 | $40,000 | $40,000 | — |
| Q4 2024 | 2024-12-31 | $18,000 | — | — |
| Q3 2024 | 2024-09-30 | $0 | — | — |
| Q2 2024 | 2024-06-30 | $0 | — | — |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | $0 | — |
| Q1 2022 | 2022-03-31 | $0 | −$35,000 | — |
| Q4 2021 | 2021-12-31 | $0 | −$263,000 | — |
| Q3 2021 | 2021-09-30 | $0 | −$288,000 | — |
| Q2 2021 | 2021-06-30 | $0 | −$26,000 | — |
| Q1 2021 | 2021-03-31 | $35,000 | −$445,000 | −92.71% |
| Q4 2020 | 2020-12-31 | $263,000 | $17,000 | +6.91% |
| Q3 2020 | 2020-09-30 | $288,000 | −$109,000 | −27.46% |
| Q2 2020 | 2020-06-30 | $26,000 | −$424,000 | −94.22% |
| Q1 2020 | 2020-03-31 | $480,000 | $426,000 | +788.89% |
| Q4 2019 | 2019-12-31 | $246,000 | −$316,000 | −56.23% |
| Q3 2019 | 2019-09-30 | $397,000 | $256,000 | +181.56% |
| Q2 2019 | 2019-06-30 | $450,000 | $398,000 | +765.38% |
| Q1 2019 | 2019-03-31 | $54,000 | −$84,000 | −60.87% |
| Q4 2018 | 2018-12-31 | $562,000 | $114,410 | +25.56% |
| Q3 2018 | 2018-09-30 | $141,000 | $141,000 | — |
| Q2 2018 | 2018-06-30 | $52,000 | $45,590 | +711.23% |
| Q1 2018 | 2018-03-31 | $138,000 | $138,000 | — |
| Q4 2017 | 2017-12-31 | $447,590 | $447,590 | — |
| Q3 2017 | 2017-09-30 | $0 | −$17,207 | — |
| Q2 2017 | 2017-06-30 | $6,410 | $6,410 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | −$23,543 | — |
| Q3 2016 | 2016-09-30 | $17,207 | $17,206 | +1720600.00% |
| Q2 2016 | 2016-06-30 | $0 | −$15,285 | — |
| Q1 2016 | 2016-03-31 | $0 | −$74,698 | — |
| Q4 2015 | 2015-12-31 | $23,543 | −$77,918 | −76.80% |
| Q3 2015 | 2015-09-30 | $1 | −$133,890 | −100.00% |
| Q2 2015 | 2015-06-30 | $15,285 | −$189,279 | −92.53% |
| Q1 2015 | 2015-03-31 | $74,698 | $65,403 | +703.64% |
| Q4 2014 | 2014-12-31 | $101,461 | $76,066 | +299.53% |
| Q3 2014 | 2014-09-30 | $133,891 | −$50,281 | −27.30% |
| Q2 2014 | 2014-06-30 | $204,564 | $187,537 | +1101.41% |
| Q1 2014 | 2014-03-31 | $9,295 | $9,295 | — |
| Q4 2013 | 2013-12-31 | $25,395 | — | — |
| Q3 2013 | 2013-09-30 | $184,172 | — | — |
| Q2 2013 | 2013-06-30 | $17,027 | — | — |
| Q1 2013 | 2013-03-31 | $0 | — | — |
CV Sciences capital expenditures (capex) trends
Over the last five fiscal years, CV Sciences's capital expenditures (capex) decreased from $1.1M to $109,000, a change of −$948,000. The latest reported quarter, Q2 2026, shows $7,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CV Sciences source filings ↗